HO-1 Nuclear Accumulation and Interaction with NPM1 Protect Against Stress-Induced Endothelial Senescence Independent of Its Enzymatic Activity
Wenwei Luo,Jingyan Li,Ziqing Li,Tong Lin,Lili Zhang,Wanqi Yang,Yanqi Mai,Ruiming Liu,Meiting Chen,Chunmei Dai,Hanwei Yang,Jing Lu,Hong Li,Guimei Guan,Min Huang,Peiqing Liu,Zhuoming Li
DOI: https://doi.org/10.1038/s41419-021-04035-6
2021-01-01
Cell Death and Disease
Abstract:Heme oxygenase-1 (HO-1) has attracted accumulating attention for its antioxidant enzymatic activity. However, the exact regulatory role of its non-enzymatic activity in the cardiovascular system remains unaddressed. Here, we show that HO-1 was accumulated in the nuclei of stress-induced senescent endothelial cells, and conferred protection against endothelial senescence independent of its enzymatic activity. Overexpression of ΔHO-1, a truncated HO-1 without transmembrane segment (TMS), inhibited H2O2-induced endothelial senescence. Overexpression of ΔHO-1H25A, the catalytically inactive form of ΔHO-1, also exhibited anti-senescent effect. In addition, infection of recombinant adenovirus encoding ΔHO-1 with three nuclear localization sequences (NLS), alleviated endothelial senescence induced by knockdown of endogenous HO-1 by CRISPR/Cas9. Moreover, repression of HO-1 nuclear translocation by silencing of signal peptide peptidase (SPP), which is responsible for enzymatic cleavage of the TMS of HO-1, exacerbated endothelial senescence. Mechanistically, nuclear HO-1 interacted with NPM1 N-terminal portion, prevented NPM1 translocation from nucleolus to nucleoplasm, thus disrupted NPM1/p53/MDM2 interactions and inhibited p53 activation by NPM1, finally resisted endothelial senescence. This study provides a novel understanding of HO-1 as a promising therapeutic strategy for vascular senescence-related cardiovascular diseases.